Seeing Diabetes Clearly: multi-organ MRI of organ health in adults with type 2 diabetes
Official title: UK Imaging Diabetes Study Seeing Diabetes Clearly
Run by Perspectum · NCT05057403 · Data updated 2026-11-12
This project will use a detailed abdominal and multi-organ MRI plus blood and urine tests to see if imaging measurements can predict future health events in adults with type 2 diabetes who have not had heart disease.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Perspectum Industry-sponsored |
| Locations | 12 sites (Didcot, Oxfordshire and 11 other locations) |
| Status | Recruiting |
| Started | May 30, 2022 |
| Main results expected | June 2034 |
| Study ends | June 2034 |
| Registry record updated | December 5, 2025 |
| Trial ID | NCT05057403 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older with type 2 diabetes, no history of cardiovascular events in the prior 12 months, and who can safely undergo MRI are ideal candidates.
✕Probably not a fit
People with recent cardiovascular events, standard MRI contraindications (for example pacemaker, pregnancy, severe claustrophobia), known significant liver or renal structural disease, or alcohol dependency are not eligible and are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, observational cohort carried out at multiple UK sites where participants undergo one baseline visit with medical history, anthropometrics and blood/urine sampling, and a second visit for a multiparametric multi-organ MRI scan within 28 days. No change to standard care is made; the MRI and biomarker data are collected once and linked to routine NHS medical records for up to five years to capture hospital admissions and mortality. The aim is to correlate MRI-derived organ health metrics with later clinical events to characterise disease progression. Enrollment is limited to adults with type 2 diabetes without a recent cardiovascular event and who can safely undergo MRI.
Why it matters
Potential benefit: If successful, MRI-derived markers could help identify people with type 2 diabetes at higher risk of complications earlier, enabling closer monitoring or targeted prevention.
How similar studies have gone: Previous imaging work has linked individual MRI measures (such as liver fat and cardiac imaging) to metabolic risk, but using a coordinated multi-organ MRI to predict long-term clinical events in type 2 diabetes is relatively novel and not yet proven.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male or female at least 18 years of age and diagnosed with type 2 diabetes, with or without diabetic retinopathy. * Participant willing and able to give informed consent for participation in the study. Exclusion Criteria: In 12 months prior to consent, evidence of existing cardiovascular event defined as at least one of: * myocardial infarction * ischaemic stroke * hospital admission/discharge for unstable angina * heart surgery * unstable angina * transient ischemic attack * The participant may not enter the study if they have any contraindication to magnetic resonance imaging (standard MR exclusion criteria including pregnancy, extensive tattoos, pacemaker, shrapnel injury, severe claustrophobia). * Patients with known autoimmune hepatitis, viral hepatitis, Wilson's disease or known significant structural renal tract abnormality. * Patients with known alcohol dependency. * Any other cause, including a significant disease or disorder which, in the opinion of the investigator, may either put the participant at risk because of participation in the study, or may influence the participant's ability to participate in the study
Where it's running
-
Woodlands Medical Centre
Didcot, Oxfordshire, United Kingdom Recruiting -
Eynsham Medical Centre
Eynsham, Oxfordshire, United Kingdom Recruiting -
White Horse Medical Practice
Farringdon, Oxfordshire, United Kingdom Recruiting -
Windrush Medical Practice
Witney, Oxfordshire, United Kingdom Recruiting -
The House Partnership
Redhill, Surrey, United Kingdom Recruiting -
University Hospitals of Liverpool Group
Liverpool, United Kingdom Recruiting
Show 6 more locations
-
The Manor Group
Oxford, United Kingdom Recruiting -
Hedena Health
Oxford, United Kingdom Recruiting -
St Bartholomew and Hollow Way Medical Practice
Oxford, United Kingdom Recruiting -
Oxford Community Diagnostic centre
Oxford, United Kingdom Recruiting -
Swansea Bay University Health Board
Baglan, Swansea, United Kingdom Not yet recruiting -
Moorfields Eye Hospital NHS Foundation Trust
London, United Kingdom Enrolling by invitation
Study contacts
- Principal investigator: Ravi Pattanshetty — Perspectum
- Study coordinator: Soubera Rymall, MSc
- Email: soubera.rymell@perspectum.com
- Phone: 00447919272482
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Investigating brain health in youth at risk for type 2 diabetes
This study is trying to see how being overweight or having blood sugar issues affects brain health in kids aged 12-17 who might be at risk for type 2 diabetes.
-
Effects of SGLT2 Inhibitors and Ketones on Heart and Muscle Health
This study is testing if a diabetes medication can change ketone levels in people with Type 2 Diabetes and heart failure to see how it affects their heart and muscle health over 12 weeks.
-
Comparing two types of gastric bypass for treating type 2 diabetes
This study is testing which type of gastric bypass surgery, one-anastomosis or Roux-en-Y, works better for helping people with obesity and type 2 diabetes lose weight and improve their diabetes.
-
Using iGlucose Device to Improve Blood Sugar Management in Pregnant Women with Diabetes
This study is testing if using the iGlucose device can help pregnant women with diabetes better manage their blood sugar levels compared to regular care.
-
Examining the effects of exercise and liraglutide on blood vessel function in Type 2 diabetes
This study is testing whether exercise, a diabetes medication called liraglutide, or a mix of both can improve blood flow and how well the body uses insulin in people with Type 2 diabetes.
-
Understanding health trends in Puerto Rico
This study is trying to understand health trends in Puerto Rico by looking at diet, mental health, and heart health in adults aged 30-75 over time.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.